Trial Profile
A study investigating efficacy and safety of Sofosbuvir and Ribavirin in kidney transplant patients with chronic hepatitis C infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 28 Dec 2015 New trial record